Balyasny Asset Management L.P.

Position in PTCT — Ptc Therapeutics, Inc.

CIK 1218710 Chicago, IL

Position in PTCT

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,680,749

-$29,697,476 QoQ

Shares Held

20,605

-95.5% QoQ

Ownership

0.025%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#156

of 383 holders

Holding Since

Jun 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Balyasny Asset Management L.P. holds $2,351,657,469 across 178 Biotechnology names. PTCT ranks #109 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	APGE	Apogee Therapeutics, Inc.	1,665,102	$221,008,988
2	INSM	INSMED Inc	1,326,430	$141,423,966
3	BBIO	BridgeBio Pharma, Inc.	1,230,052	$91,614,272
4	ABVX	Abivax S.A.	603,840	$80,467,718
5	VRTX	Vertex Pharmaceuticals Inc / Ma	145,005	$72,028,333
6	TNGX	Tango Therapeutics, Inc.	2,016,379	$63,032,007
7	CYTK	Cytokinetics Inc	711,676	$60,627,678
8	BMRN	Biomarin Pharmaceutical Inc	1,054,613	$60,344,955

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,680,749	20,605	-95.5%	Shares	Sole	2026-08-14
2026-03-31	$31,378,225	460,564	+380.1%	Shares	Sole	2026-05-15
2025-09-30	$5,886,917	95,925	+53.4%	Shares	Sole	2025-11-14
2024-09-30	$2,320,567	62,549	-31.6%	Shares	Sole	2024-11-14
2023-03-31	$4,429,159	91,436	-9.4%	Shares	Other	2023-05-15
2022-12-31	$3,852,574	100,932	-7.7%	Shares	Sole	2023-02-14
2022-03-31	$4,081,788	109,402	+31.1%	Shares	Sole	2022-05-16
2021-12-31	$3,322,698	83,422	-23.0%	Shares	Sole	2022-02-14
2021-09-30	$4,029,545	108,292	-55.8%	Shares	Sole	2021-12-01
2021-06-30	$10,349,048	244,832	+4360.4%	Shares	Sole	2021-08-16
2020-09-30	$256,610	5,489	-27.8%	Shares	Sole	2020-11-16
2020-06-30	$385,522	7,598	—	Shares	Sole	2020-08-14
No filing history on record for this holder in this stock.